Close Menu
Home › NuGenerex Gets CE Mark for Point-of-Care Syphilis Assay

NuGenerex Gets CE Mark for Point-of-Care Syphilis Assay

Jan 24, 2019

NEW YORK (360Dx) — NuGenerex Diagnostics announced today that it has received CE marking for its rapid, point-of-care syphilis test called the Express II Syphilis TreponemalAssay.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Apr
30
Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

What's Popular?

In Infectious Disease

  1. Roche Reports Flat Q1 Diagnostics Sales

  2. Cepheid Outlines Assay Improvements, Xpert Cartridge Partnering Program at ECCMID

    Premium

  3. iCubate, Wondfo Biotech Form Chinese JV to Develop MDx Assays

  4. XCR Diagnostics to Develop Assays for NeuMoDx Systems

  5. GenMark Diagnostics Obtains FDA Clearance for Gram-Negative Sepsis Panel

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.